
Researchers were drowning in raw genomic data, unable to quickly identify genetic markers relevant to rare diseases.
A leading biotech firm focused on personalized cancer therapies.
A cloud-native genomics platform that pipelines raw sequencing data into actionable insights using ML-driven variant classification.